Back
Actinium Pharmaceuticals Stock Price Chart
Sponsored
ATNM
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
25
ATNM
Actinium Pharmaceuticals
Last Price:
1.82
Seasonality Move:
-4.37%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing selling pressure, which indicates risk of future bearish movement.
Actinium Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.85 | Sell |
20-day SMA: | 1.88 | Sell |
50-day SMA: | 3.7 | Sell |
200-day SMA: | 6.22 | Sell |
8-day EMA: | 1.84 | Sell |
20-day EMA: | 2.06 | Sell |
50-day EMA: | 3.37 | Sell |
200-day EMA: | 5.78 | Sell |
Actinium Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 32.62 | Sell |
Chaikin Money Flow: | -343456 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.79 - 2.03) | Sell |
Bollinger Bands (100): | (3.02 - 8.82) | Sell |
Actinium Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Actinium Pharmaceuticals Stock
Is Actinium Pharmaceuticals Stock a Buy?
- Actinium Pharmaceuticals share price is 1.80 while ATNM 8-day simple moving average is 1.85, which is a Sell signal.
- The stock price of ATNM is 1.80 while Actinium Pharmaceuticals 20-day SMA is 1.88, which makes it a Sell.
- Actinium Pharmaceuticals 50-day simple moving average is 3.70 while ATNM share price is 1.80, making it a Sell technically.
- ATNM stock price is 1.80 and Actinium Pharmaceuticals 200-day simple moving average is 6.22, creating a Sell signal.
ATNM Technical Analysis vs Fundamental Analysis
Sell
25
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy or a Sell?
-
Actinium Pharmaceuticals stock is rated a Sell
The current Actinium Pharmaceuticals [ATNM] share price is $1.80. The Score for ATNM is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Actinium Pharmaceuticals Stock Info
Market Cap:
56.08M
Price in USD:
1.80
Share Volume:
496.1K
Actinium Pharmaceuticals 52-Week Range
52-Week High:
10.24
52-Week Low:
1.33
Sell
25
Actinium Pharmaceuticals (ATNM)
is a Sell
Actinium Pharmaceuticals Share Price Forecast
-
What is the Actinium Pharmaceuticals stock price today?
The Actinium Pharmaceuticals stock price is 1.80 USD today. -
Will ATNM stock go up or go down?
Actinium Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Actinium Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Actinium Pharmaceuticals is overvalued.
Is Actinium Pharmaceuticals Stock a Buy?
- Actinium Pharmaceuticals share price is 1.80 while ATNM 8-day exponential moving average is 1.84, which is a Sell signal.
- The stock price of ATNM is 1.80 while Actinium Pharmaceuticals 20-day EMA is 2.06, which makes it a Sell.
- Actinium Pharmaceuticals 50-day exponential moving average is 3.37 while ATNM share price is 1.80, making it a Sell technically.
- ATNM stock price is 1.80 and Actinium Pharmaceuticals 200-day simple moving average is 5.78, creating a Sell signal.
Fundamental Analysis of Actinium Pharmaceuticals
Is Actinium Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.09 per share, an increase this year of $0.62 per share, and an increase next year of $0.66 per share.
Technical Analysis of Actinium Pharmaceuticals
Should I short Actinium Pharmaceuticals stock?
- ATNM Moving Average Covergence Divergence (MACD) indicator is -0.42, suggesting Actinium Pharmaceuticals is a Sell
- Actinium Pharmaceuticals Relative Strength Index (RSI) is 32.62, which suggest Actinium Pharmaceuticals is oversold
- The Bollinger Bands (25) for Actinium Pharmaceuticals is (1.79 - 2.03), which suggest Actinium Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Actinium Pharmaceuticals is (3.02 - 8.82), which suggest Actinium Pharmaceuticals is a Sell
* Actinium Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.